Cancer cell growth, migration, tumourigenesis and chemoresistance can all be impacted by targeting the proteins involved in the IRAK2 pathway, including IRAK1 and IRAK4 [27,28,29,30]. This evidence concerns the gene IRAK4 and cancer.